MSI Financial Services’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$162K Buy
13,088
+9,000
+220% +$108K 0.01% 1203
2016
Q3
$56K Sell
4,088
-1,015
-20% -$10.2K ﹤0.01% 1765
2016
Q2
$38K Sell
5,103
-62
-1% -$465 ﹤0.01% 1968
2016
Q1
$33K Buy
5,165
+3,715
+256% +$20.8K ﹤0.01% 2013
2015
Q4
$9K Buy
1,450
+100
+7% +$656 ﹤0.01% 2803
2015
Q3
$8K Sell
1,350
-750
-36% -$5.78K ﹤0.01% 2208
2015
Q2
$17K Hold
2,100
﹤0.01% 1884
2015
Q1
$17K Buy
2,100
+750
+56% +$5.54K ﹤0.01% 1905
2014
Q4
$9K Buy
1,350
+1,000
+286% +$6.25K ﹤0.01% 1910
2014
Q3
$2K Hold
350
﹤0.01% 2458
2014
Q2
$2K Sell
350
-300
-46% -$2.06K ﹤0.01% 2406
2014
Q1
$5K Buy
650
+648
+32,400% +$5.05K ﹤0.01% 2042
2013
Q4
$0 Sell
2
-498
-100% -$2.69K ﹤0.01% 2660
2013
Q3
$9K Hold
500
﹤0.01% 1511
2013
Q2
$9K Buy
+500
New +$8.86K ﹤0.01% 1617

Other funds holding ARIA

MSI Financial Services's ARIA Position: Q4 2016 in Review

MSI Financial Services increased its Ariad Pharmaceuticals Inc (ARIA) stake by 220% in Q4 2016, buying an estimated $108K and bringing the position to 13,088 shares worth $162K. The position accounts for 0.01% of the portfolio, ranked #1203.

MSI Financial Services first reported a position in ARIA in Q2 2013 and has held it in 15 quarters since. 200 funds tracked by Wall St. Rank hold ARIA as of Q4 2016.

  • MSI Financial Services held 13,088 shares of Ariad Pharmaceuticals Inc worth $162K as of Q4 2016.
  • MSI Financial Services bought 9,000 Ariad Pharmaceuticals Inc shares in Q4 2016, an estimated $108K.
  • Ariad Pharmaceuticals Inc made up 0.01% of MSI Financial Services's portfolio in Q4 2016, its #1203 holding.
  • MSI Financial Services first reported a position in Ariad Pharmaceuticals Inc in Q2 2013 and has held it in 15 quarters since.
  • 200 funds tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q4 2016.

Based on MSI Financial Services's 13F filing for Q4 2016, filed 13 Jan 2017.